Villegas, Anchelle S.

HRN: 28-29-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2025
CEFTAZIDIME 1GM (VIAL)
12/21/2025
12/28/2025
IV
1g
Q8H
VAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines